Previsioni di mercato della marijuana medica per il Nord America fino al 2028 - Impatto del COVID-19 e analisi regionale - per tipo di prodotto (forma secca e forma di estratto), applicazione (gestione del dolore, sindrome di Tourette, morbo di Alzheimer, emicrania, depressione e ansia, Sclerosi multipla, cancro e altri) e canale di distribuzione (farmacia al dettaglio, commercio elettronico e altri)

Si prevede che il mercato della marijuana medica in Nord America crescerà da 7.170,17 milioni di dollari nel 2022 a 20.760,41 milioni di dollari entro il 2028. Si stima che registrerà un CAGR del 19,4% dal 2022 al 2028. ;

L\'aumento delle approvazioni di prodotti a base di marijuana medica alimenta la crescita del mercato della marijuana medica in Nord America

< p>Il potenziale medicinale della marijuana ha attratto vari ricercatori e aziende a utilizzare la marijuana in applicazioni mediche. Il tetraidrocannabinolo (THC), ad esempio, viene utilizzato prevalentemente per la produzione di medicinali. La Food and Drug Administration (FDA) statunitense ha approvato prodotti medicinali a base di THC come Cesamet, che contiene nabolina come principio attivo, è un prodotto di derivazione sintetica che ha una struttura simile al THC. Cesamet è prescritto per il trattamento della nausea nei pazienti sottoposti a chemioterapia. Cesamet viene generalmente prescritto quando altri farmaci non riescono a controllare la nausea e il vomito. La FDA ha inoltre approvato Marinol e Syndros per usi terapeutici negli Stati Uniti. Marinol e Syndros contengono il principio attivo dronabinol, un 9-THC sintetico considerato il componente psicoattivo della cannabis. I farmaci Marinol e Syndros sono prescritti per stimolare l\'appetito nei pazienti con sindrome da deperimento, sviluppata come una delle indicazioni dell\'AIDS. Allo stesso modo, vari prodotti a base di marijuana sono stati approvati o sono in fase di sperimentazione clinica. Ad esempio, il nabiximols (Sativex) è un farmaco approvato commercializzato in Canada. Nabiximols è un estratto di cannabis usato per trattare la spasticità e il dolore neuropatico legati alla sclerosi multipla. È formulato con una combinazione di THC e altri cannabidioli (CBD). Nel febbraio 2020, CanaQuest Medical Corp, una società canadese, ha richiesto l\'approvazione della produzione e della commercializzazione del mentabinolo a Health Canada. Il mentabinolo è un prodotto a base di THC e la sua richiesta di approvazione è stata depositata ai sensi del Cannabis Act. L\'aumento dell\'approvazione dei suddetti prodotti a base di marijuana da parte della FDA sta guidando il mercato della marijuana medica.

Panoramica del mercato della marijuana medica in Nord America

Il mercato della marijuana medica in Nord America è segmentato in Stati Uniti, Canada e Messico. Si stima che il mercato della marijuana medica abbia la quota maggiore negli Stati Uniti. La crescita del mercato della marijuana medica può essere attribuita alla crescente ricerca e alle collaborazioni per esplorare applicazioni terapeutiche innovative, alla crescente consapevolezza riguardo alla marijuana medica e alla presenza di attori chiave nella regione. Inoltre, anche il crescente invecchiamento della popolazione nella regione favorirà la crescita del mercato.

Entrate e previsioni del mercato della marijuana medica del Nord America fino al 2028 (Stati Uniti milioni di dollari)

Mercato della marijuana medica in Nord America Segmentazione

Il mercato della marijuana medica in Nord America è segmentato in tipo di prodotto, applicazione, canale di distribuzione e paese.

In base al tipo di prodotto, il mercato della marijuana medica in Nord America è segmentato in forma essiccata e forma estratta. Nel 2022, il segmento degli estratti ha detenuto una quota maggiore del mercato della marijuana medica in Nord America.

In base all\'applicazione, il mercato della marijuana medica in Nord America è segmentato in gestione del dolore, Tourette, morbo di Alzheimer, emicrania, depressione e ansia, sclerosi multipla, cancro e altri. Il segmento della gestione del dolore ha detenuto la quota maggiore del mercato della marijuana medica in Nord America nel 2022.

In base al canale di distribuzione, il mercato della marijuana medica in Nord America è segmentato in farmacia al dettaglio, e -commercio e altri. Il segmento delle farmacie al dettaglio ha detenuto la quota maggiore del mercato della marijuana medica in Nord America nel 2022.

In base al paese, il mercato della marijuana medica in Nord America è segmentato in Stati Uniti, Canada, e Messico. Gli Stati Uniti hanno dominato il mercato della marijuana medica in Nord America nel 2022.

Aphria, Inc.; CanaQuest Medical Corporation; Società per la crescita della tettoia; Smeraldo Salute Therapeutics Inc.; Prodotti farmaceutici GW; MARICANN INC.; Organigramma Holdings Inc.; Panaxia Industrie Farmaceutiche Ltd.; Phoena Holdings Inc.; e VIVO Cannabis Inc sono le aziende leader che operano nel mercato della marijuana medica del Nord America.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Medical Marijuana Market – by Product

1.3.2 North America Medical Marijuana Market – by Application

1.3.3 North America Medical Marijuana Market – by Distribution Channel

1.3.4 North America Medical Marijuana Market – by Country

2. North America Medical Marijuana Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Medical Marijuana Market – Market Landscape

4.1 Overview

4.2 North America – PEST Analysis

4.3 Expert Opinion

5. North America Medical Marijuana Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Approvals of Medical Marijuana Products

5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America

5.2 Market Restraints

5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana

5.3 Market Opportunities

5.3.1 Increase in Job Opportunities in Marijuana Industry

5.4 Future Trends

5.4.1 Widespread Distribution of Medical Marijuana

5.5 Impact Analysis

6. Medical Marijuana Market – North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

7.3 Dried Form

7.3.1 Overview

7.3.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Extract Form

7.4.1 Overview

7.4.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis – by Application

8.1 Overview

8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

8.3 Pain Management

8.3.1 Overview

8.3.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Tourette’s

8.4.1 Overview

8.4.2 Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Alzheimer’s Disease

8.5.1 Overview

8.5.2 Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Migraines

8.6.1 Overview

8.6.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Depression and Anxiety

8.7.1 Overview

8.7.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Multiple Sclerosis

8.8.1 Overview

8.8.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Cancer

8.9.1 Overview

8.9.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market – by Distribution Channel

9.1 Overview

9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

9.3 Retail Pharmacy

9.3.1 Overview

9.3.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.4 E-Commerce

9.4.1 Overview

9.4.2 E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2 US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2 Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2 Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Medical Marijuana Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Panaxia Pharmaceutical Industries Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Phoena Holdings Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Emerald Health Therapeutics Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 MARICANN INC.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Aphria, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Canopy Growth Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CanaQuest Medical Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 GW Pharmaceuticals

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Organigram Holdings Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for North America Medical Marijuana Market

LIST OF TABLES

Table 1. US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 3. US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 6. Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 9. Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10. Organic Developments in the Medical Marijuana Market

Table 11. Inorganic Developments in the Medical Marijuana Market

Table 12. Glossary of Terms for North America Medical Marijuana Market

LIST OF FIGURES

Figure 1. North America Medical Marijuana Market Segmentation

Figure 2. North America Medical Marijuana Market, By Country

Figure 3. North America Medical Marijuana Market Overview

Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market

Figure 5. US to Show Remarkable Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

Figure 9. Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

Figure 12. Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

Figure 21. Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

Figure 26. US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000